Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

256.96 +1.08 (+0.42%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Expert Outlook: ResMed Through The Eyes Of 9 Analysts
Via Benzinga
Peering Into ResMed's Recent Short Interest
Via Benzinga
ASX : RMD - Resmed Stock Analysis & Elliott Wave Technical Forecast
Our Elliott Wave analysis updates the Australian Stock Exchange with Resmed Inc shares. We have identified an Expanded Flat correction pattern, indicating the potential for RMD to continue declining... 
Via Talk Markets
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock. 
Via Chartmill
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode. 
Via The Motley Fool
Uncovering Dividend Opportunities with NYSE:RMD.
Why RESMED INC (NYSE:RMD) provides a good dividend, while having solid fundamentals. 
Via Chartmill
Cracking The Code: Understanding Analyst Reviews For ResMed
Via Benzinga
Why ResMed Stock Is Jumping Today
The medical device maker beat expectations with its latest quarterly results. 
Via The Motley Fool
Recap: ResMed Q2 Earnings
Via Benzinga
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
Via Benzinga
ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line
ResMed reported better-than-expected sales and adjusted earnings. 
Via Investor's Business Daily
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
It’s not easy to find sleep stocks to buy despite the fact the industry is booming these days from society's lack of rest and relaxation. 
Via InvestorPlace
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious
ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall. 
Via Benzinga
Topics Product Recall
If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today
Via Benzinga
Demystifying ResMed: Insights From 5 Analyst Reviews
Via Benzinga
Uncovering Dividend Opportunities with NYSE:RMD.
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock. 
Via Chartmill
Earnings Scheduled For January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion. 
Via Benzinga
ResMed's Earnings: A Preview
Via Benzinga
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
Exploring RESMED INC (NYSE:RMD)'s dividend characteristics. 
Via Chartmill
$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Top Picks 2024: ResMed
ResMed is the market leader in continuous positive airway pressure machines. ResMed has enjoyed a steadily growing market throughout its history, and investors have often paid sky-high valuations for... 
Via Talk Markets
(RMD) - Analyzing ResMed's Short Interest
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today
Via Benzinga
Why NYSE:RMD qualifies as a good dividend investing stock.
Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing? 
Via Chartmill
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump. 
Via Benzinga
Why the dividend investor may take a look at NYSE:RMD.
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential. 
Via Chartmill
2 Monster Stocks to Buy Without Any Hesitation
Down 33% and 44%, these two stocks look too good to pass up today. 
Via The Motley Fool
How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In
Needham analyst Mike Matson reiterated a Buy rating on ResMed Inc. (NYSE: RMD)  
Via Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.